Death with Dipyridamole-Thallium Imaging
- Harold Z. Friedman, MD;
- Scot F. Goldberg, MD;
- Andrew M. Hauser, MD; and
- William W. O'Neill, MD
Excerpt
Dipyridamole-thallium 201 cardiac imaging is a sensitive and specific test for detecting coronary artery disease in patients unable to exercise effectively (1-3). Minor side effects from dipyridamole administration are common; however, morbidity is rare, and death has never been reported.
A 77-year-old woman was hospitalized for increasingly severe, atypical chest pain. Her medical history showed hypertension and calf claudication. The results of recent echocardiographic study had shown concentric left ventricular hypertrophy, with normal contractility and aortic valve thickening. The peak aortic gradient was 20 mm Hg by Doppler study. Physical examination showed bilateral carotid bruits and fine bibasilar rales. Heart
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
